Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Patient Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.
"Patient Capital Management delivered strong 2023 performance, capitalizing on market panic to buy high-return banks like UBS and Western Alliance. While trimming top winners, the manager remains bullish on historically cheap classic value stocks and select mega-cap compounders, supported by a constructive economic backdrop and a pivoting Federal Reserve."
Patient Capital Management’s Opportunity Equity strategy delivered strong performance in 2023, advancing 37.58% net of fees and outperforming the S&P 500's 26.29% return. In her Q4 2023 letter, manager Samantha McLemore outlines a constructive outlook driven by moderating inflation, a solid US economy, and a supportive Federal Reserve pivot toward interest rate cuts. While macro indicators have improved, investor skepticism remains elevated, leaving substantial cash in money market funds that could fuel further equity gains. The portfolio is positioned across low-multiple classic value stocks, which are historically undervalued, and selective mega-cap secular compounders like Amazon, Alphabet, and Meta. During the quarter, the fund capitalized on healthcare sector weakness to buy Royalty Pharma and Illumina, and added to Crocs. They also trimmed top performers like Uber and Coinbase as they neared fair value. McLemore candidly reflects on past process errors, notably Farfetch’s bankruptcy, emphasizing the need for stricter evaluation of operational and financial discipline in early-stage companies and establishing a "wall of shame" to institutionalize these critical lessons.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
A score of 0.75 reflects high conviction. The portfolio exhibits concentrated focus, holding deep-value assets such as regional banks (UBS, WAL) through volatile times, and maintaining significant, high-conviction positions in mega-cap technology firms like Amazon, Alphabet, and Meta.
Growth Outlook
The score is 0.75 because the manager is constructive on the market's ongoing bull run, citing improved disinflation, strong economic growth, and the Fed pivot, while welcoming investor skepticism as a healthy indicator for further potential equity upside.
Risk Appetite
A score of 0.75 indicates a strong risk appetite. The manager remains net long and continues to favor high-margin regional banks and deeply discounted value cyclicals, showing a willingness to accept high single-stock volatility in exchange for significant long-term returns.
Capital Deployment
The score of 0.75 represents moderate capital deployment activity, characterized by selling and trimming top gainers like Uber and Coinbase to redeploy cash into newly identified opportunities like Royalty Pharma, Illumina, and Crocs during periods of market weakness.
Forward Guidance
The score is 0.75 because the manager outlines concrete actions, explaining their active buying of beaten-down healthcare stocks and consumer names, while trimming winners that have approached calculated fair values.
Language Signal
A score of 0.70 represents constructive language. The manager uses optimistic, value-oriented terms like 'attractive prices', 'handsome return potential', and 'undervalued' while balancing this with a highly candid, analytical discussion of mistakes made with Farfetch.
Perceived Risk
A score of 0.50 reflects moderate risk perception. Standard risk factors like interest rates and recession are noted but are considered diminished due to the Fed pivot, though the non-negligible tail risk of an AI-bubble is explicitly addressed.
Opportunity Density
The score of 0.80 indicates a very rich opportunity set. The manager believes that classic value has been left for dead, presenting excellent mispricings, and highlights selective opportunities within both the healthcare sector and among the Magnificent Seven.
Time Horizon
The score of 0.85 indicates a strong multi-year focus. This is anchored by the letter's opening quote by Charlie Munger on the importance of 'waiting', the manager's description of their strategy as long-term value, and their explicitly noted holding periods of 5+ years.
